Therapeutic effect of ent-kaur-16-en-19-oic acid on neutrophilic lung inflammation and sepsis is mediated by Nrf2
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q2Scopus Q2
- 저널
- BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS474(3) · pp.534 · 2016
- 피인용
- Web of Science 26
- JCR IF
- JCR 2015 2.371
- ISSN
- 0006-291X
저자
초록
Kaurenoic acid (ent-kaur-16-en-19-oic acid: KA) is a key constituent found in the roots of Aralia continentalis Kitagawa (Araliaceae), a remedy to treat patients with inflammatory diseases in traditional Asian medicine. Since KA activates Nrf2, a key anti-inflammatory factor, at the cellular level, we explored a possible therapeutic usage of KA against neutrophilic inflammatory lung disease such as acute lung injury (ALI). Intraperitoneal (i.p.) injection of lipopolysaccharide (LPS) to C57BL/6 mice induced lung inflammation as in ALI. 2 h after i.p. LPS, intratracheal (i.t.) delivery of KA (0.3, 3, or 30 mu g/kg body weight) improved lung structure and significantly suppressed neutrophil infiltrations to mouse lungs, with concomitant reduction of myeloperoxidase activity and of the expression of pro-inflammatory cytokine genes. While activating Nrf2 and expressing Nrf2-dependent genes in mouse lungs, KA did not significantly suppress neutrophil lung inflammation in Nrf2 KO mice. In a mouse model of sepsis, a major cause of ALI, single i.t. KA (3 mu g/kg) 2 h after the onset of sepsis significantly decreased the mortality of mice. Together, these results suggest that KA has a therapeutic potential against inflammatory lung disease, the effect of which is associated with Nrf2 activation. (C) 2016 Elsevier Inc. All rights reserved.
키워드
Kaurenoic acidAnti-inflammationNrf2Neutrophilic lung inflammationSepsisRESPIRATORY-DISTRESS-SYNDROMEARALIA-CONTINENTALISENHANCES SUSCEPTIBILITYMEDICAL PROGRESSKAURENOIC ACIDINJURYMICEPATHOPHYSIOLOGYCONSTITUENTSEXPRESSION
식별자
- WoS UID
- 000377150100018



로그인
연구물 목록으로